So nice to exchange ideas, celebrate the liver, and grow the community of #alcoholrelated liver disease research!

The SALVE group meeting in person to push research in ALD forward! Thanks to Carolin for arranging, we are looking forward to a productive day
@easlnews.bsky.social

We made the cover of Hepatology 👏👏
@aleksanderkrag.bsky.social #LiverSky

journals.lww.com/hep/fulltext...

This is so far the most interesting article of 2025: The real-world leaky pipeline when screening for fibrosis and cirrhosis.

Less than 11% of VA patients with FIB-4≥3.25 could/would enter into elastography case finding program:
bmchealthservres.biomedcentral.com/articles/10....

@suguru-nishijima.bsky.social @borklab.bsky.social @biocs.bsky.social @evelinastn.bsky.social @majathiele.bsky.social @aleksanderkrag.bsky.social

I recap 2024, month-by-month #LiverSky

🗓️MAY:
AASLD Practice Guidance on risk stratification & management of portal HT & varices in cirrhosis

👉From A to Z on 🔝 elastography and blood based NILTs

Read here👇
journals.lww.com/hep/fulltext...

@dougsimonetto.bsky.social @amergastroassn.bsky.social

My #LiverSky recap of 2024

MARCH was kick-off month for
@liveraim.bsky.social ‼️
Learn more: liveraim.eu

LIVERAIM sets direction for biomarker research & implementation, including POSITIVE: the largest RCT in hepatology, with n=100,000
@aleksanderkrag.bsky.social @salvatore-piano.bsky.social

Recap of 2024 for #LiverSky

📅FEBRUARY was omics month:
@jhepatology.bsky.social review on opportunities & barriers for omics as biomarkers

💪Powerful technologies which we are only now starting to explore in clinical care

🔗https://www.journal-of-hepatology.eu/article/S0168-8278(24)00219-8/fulltext

Tak @majahorst.bsky.social - det betyder meget at en så garvet forsker & formidler som dig synes mine overvejelser var interessante!

2024 marked a year of liver biomarker research #LiverSky

➡️Next 12 days I will post a summary of publications and collaborations, one month per day.

JANUARY:
Kicked off with a review on algorithms for early fibrosis detection, including the growing role of AI: www.thieme-connect.com/products/ejo...

Thanks Atoosa - looking forward to exploring Bluesky + Liver

The three critical rules of biomarker appraisal:

✋Truthful? = analytical validity
👍Meaningful? = clinical validity
🙌Useful? = clinical utility

youtu.be/zCjxDeyXgfU?...
#liversky #biomarkers #medicine

Hi Peder - we're coming! Slow learners, but here now 👍